Showing results (61-70 of 227) with videos related to
Sort By:
Pageof 23
Cell Host & Microbe|June 10, 2025
Interferon-epsilon, an estrogen-induced type I interferon, is uniquely exploited by Neisseria gonorrhoeae via effects on sialic acid metabolismEvelyn A Kurt-Jones, Sunita Gulati, Michael King, et al.Current Infectious Disease Reports|September 4, 2008
16S-Ribosomal DNA to diagnose culture-negative endocarditisGuillermo E Madico, Peter A RiceArthritis Care & Research|November 12, 2014
Temporal effect of depressive symptoms on the longitudinal evolution of rheumatoid arthritis disease activityAlan M Rathbun, Leslie R Harrold, George W ReedRheumatology (Oxford, England)|December 14, 2012
The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic reviewAlan M Rathbun, George W Reed, Leslie R HarroldClinical Rheumatology|August 27, 2014
Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptomsAlan M Rathbun, Leslie R Harrold, George W ReedClinical and Experimental Rheumatology|July 2, 2014
A description of patient- and rheumatologist-reported depression symptoms in an American rheumatoid arthritis registry populationAlan M Rathbun, Leslie R Harrold, George W ReedAnnals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 27, 2009
Brief patient-centered clinician-delivered counseling for high-risk drinking: 4-year resultsJudith K Ockene, George W Reed, Sarah Reiff-HekkingThe Journal of Rheumatology|July 3, 2010
A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological researchMary J Bentley, Jeffrey D Greenberg, George W ReedClinical Therapeutics|July 3, 2016
A Prospective Evaluation of the Effects of Prevalent Depressive Symptoms on Disease Activity in Rheumatoid Arthritis Patients Treated With Biologic Response ModifiersAlan M Rathbun, Leslie R Harrold, George W ReedClinical and Vaccine Immunology : CVI|June 7, 2013
Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?Dan M Granoff, Sanjay Ram, Peter T BeerninkPageof 23